December 27, 2014

Day One of 2015 PharmaLink Conference to Feature FDA’s Melinda Plaisier

Day One of 2015 PharmaLink Conference to Feature FDA’s Melinda Plaisier

FDA’s Melinda Plaisier, Associate Commissioner for Regulatory Affairs will share the vision for implementation of the Program Alignment initiative and will discuss the benefits and risks to the program with participants.  Based on FDASIA, FDA has been given the authority from Congress to conduct risk-based inspections and to utilize its resources using risk-based decisions.  Hear how FDA is working to utilize this authority and the impact it may have on you.  To view the program & agenda click here.